# Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE)

> **NCT03891277** · PHASE2 · UNKNOWN · sponsor: **Beijing Tiantan Hospital** · enrollment: 1006 (estimated)

## Conditions studied

- Vascular Cognitive Impairment
- Dementia, Vascular
- Iron-deficiency
- Cerebral Infarction
- TIA

## Interventions

- **DRUG:** Ferrous succinate

## Key facts

- **NCT ID:** NCT03891277
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-04-01
- **Primary completion:** 2021-10-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 1006 (ESTIMATED)
- **Last updated:** 2020-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03891277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03891277, "Efficacy and Safety of Ferrous Iron on the Prevention of Vascular Cognitive Impairment Among Patients With Cerebral Infarction/TIA (FAVORITE)". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03891277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*